NEWS

2 december 2019
2 december 2019

Xenikos appoints Stanley Musial as Chief Financial Officer and Chief Business Officer

Do you like it?
Read more
14 oktober 2019
14 oktober 2019

Xenikos receives FDA Fast Track designation for T-Guard® for treating steroid-refractory acute graft-versus-host disease

Do you like it?
Read more
11 juni 2019
11 juni 2019

Xenikos announces IND clearance by the FDA for a pivotal Phase 3 trial using T-Guard® for treating steroid-refractory acute GVHD

Do you like it?
Read more
Load more